ANAB - Anaptys Announces Participation in November Investor Conferences | Benzinga
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its senior management team are scheduled to participate in multiple upcoming investor conferences in November:
Investor Conference Details
Guggenheim 5th Annual I&I Conference, New York, NY
- Format – Fireside chat and one-on-one investor meetings
- Date and Time – Tuesday, Nov. 7, 2023 at 9:50am ET / 6:50am PT
UBS Biopharma Conference 2023, Miami, FL
- Format – One-on-one investor meetings
- Date – Wednesday, Nov. 8, 2023
Stifel 2023 Healthcare Conference, New York, NY
- Format – Fireside chat and one-on-one investor meetings
- Date and Time – Wednesday, Nov. 15, 2023 at 12:40pm ET / 9:40am PT
Piper Sandler 35th ...